Economic burden of relapsed/refractory chronic lymphocytic leukemia.

被引：2
|
作者：
Guerin, Annie
Ray, Saurabh
Gauthier, Genevieve
Hsu, Ling-I
Zhdanava, Maryia
Heroux, Julie
Wu, Eric Qiong
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] AbbVie, N Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e18065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18065
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Lenalidomide active in patients with refractory or relapsed chronic lymphocytic leukemia
    Nature Clinical Practice Oncology, 2007, 4 (3): : 143 - 143
  • [32] Ofatumumab and Complement Replacement in Relapsed/Refractory Chronic Lymphocytic Leukemia
    Tuscano, Joseph
    Poh, Christina
    Rosenberg, Aaron
    Jonas, Brian
    Abedi, Mehrdad
    Barisone, Gustavo
    Schwab, Emily
    Lundeberg, Kathleen
    Kaesberg, Paul
    JOURNAL OF HEMATOLOGY, 2020, 9 (03) : 79 - 83
  • [33] Phase I study of rituximab and CAMPATH-1H in patients with relapsed or refractory chronic lymphocytic leukemia.
    Nabhan, C
    Tallman, MS
    Riley, MB
    Fitzpatrick, J
    Gordon, LI
    Gartenhaus, R
    Kuzel, T
    Siegel, R
    Rosen, ST
    BLOOD, 2001, 98 (11) : 365A - 365A
  • [34] CLADRIBINE IN THE TREATMENT OF RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA
    TALLMAN, MS
    HAKIMIAN, D
    ZANZIG, C
    HOGAN, DK
    RADEMAKER, A
    ROSE, E
    VARIAKOJIS, D
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) : 983 - 988
  • [35] The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia
    Nair, Kruti Sheth
    Cheson, Bruce
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (02) : 69 - 84
  • [36] Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia
    Niemann, Carsten U.
    Levin, Mark-David
    Dubois, Julie
    Kersting, Sabina
    Enggaard, Lisbeth
    Veldhuis, Gerrit J.
    Mous, Rogier
    Mellink, Clemens H. M.
    Dobber, Johan A.
    Poulsen, Christian B.
    Frederiksen, Henrik
    Janssens, Ann
    Schjodt, Ida
    Dompeling, Ellen C.
    Ranti, Juha
    Mattsson, Mattias
    Bellido, Mar
    Tran, Hoa T. T.
    Nasserinejad, Kazem
    Kater, Arnon P.
    BLOOD, 2021, 137 (08) : 1117 - 1120
  • [37] Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia
    Reagan, John L.
    Castillo, Jorge J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (02) : 151 - 160
  • [38] Apoptosis in chronic lymphocytic leukemia.
    Giordano, M
    MEDICINA-BUENOS AIRES, 2000, 60 : 12 - 16
  • [39] Fludarabine for chronic lymphocytic leukemia.
    Proctor, SJ
    Mounter, P
    Summerfield, GP
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (15): : 1167 - 1167
  • [40] Allelotyping of chronic lymphocytic leukemia.
    Starostik, P
    OBrien, S
    Manshouri, T
    Haidar, M
    Kantarjian, H
    Freireich, E
    Keating, M
    Albitar, M
    BLOOD, 1997, 90 (10) : 397 - 397
12345